178 related articles for article (PubMed ID: 27579547)
1. Serum amyloid A and atherosclerosis.
Getz GS; Krishack PA; Reardon CA
Curr Opin Lipidol; 2016 Oct; 27(5):531-5. PubMed ID: 27579547
[TBL] [Abstract][Full Text] [Related]
2. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.
Krishack PA; Bhanvadia CV; Lukens J; Sontag TJ; De Beer MC; Getz GS; Reardon CA
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187995
[TBL] [Abstract][Full Text] [Related]
3. Acute-phase serum amyloid A: perspectives on its physiological and pathological roles.
Kisilevsky R; Manley PN
Amyloid; 2012 Mar; 19(1):5-14. PubMed ID: 22320226
[TBL] [Abstract][Full Text] [Related]
4. A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis.
Hua S; Song C; Geczy CL; Freedman SB; Witting PK
Redox Rep; 2009; 14(5):187-96. PubMed ID: 19843373
[TBL] [Abstract][Full Text] [Related]
5. Role of serum amyloid A in atherosclerosis.
Shridas P; Tannock LR
Curr Opin Lipidol; 2019 Aug; 30(4):320-325. PubMed ID: 31135596
[TBL] [Abstract][Full Text] [Related]
6. Serum Amyloid A (SAA) Proteins.
Sack GH
Subcell Biochem; 2020; 94():421-436. PubMed ID: 32189310
[TBL] [Abstract][Full Text] [Related]
7. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice.
Lewis KE; Kirk EA; McDonald TO; Wang S; Wight TN; O'Brien KD; Chait A
Circulation; 2004 Aug; 110(5):540-5. PubMed ID: 15277327
[TBL] [Abstract][Full Text] [Related]
8. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein.
Ji A; Trumbauer AC; Noffsinger VP; de Beer FC; Webb NR; Tannock LR; Shridas P
J Lipid Res; 2023 May; 64(5):100365. PubMed ID: 37004910
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A in atherosclerosis.
King VL; Thompson J; Tannock LR
Curr Opin Lipidol; 2011 Aug; 22(4):302-7. PubMed ID: 21734573
[TBL] [Abstract][Full Text] [Related]
11. The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein.
Witting PK; Song C; Hsu K; Hua S; Parry SN; Aran R; Geczy C; Freedman SB
Free Radic Biol Med; 2011 Oct; 51(7):1390-8. PubMed ID: 21784147
[TBL] [Abstract][Full Text] [Related]
12. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.
Marsche G; Frank S; Raynes JG; Kozarsky KF; Sattler W; Malle E
Biochem J; 2007 Feb; 402(1):117-24. PubMed ID: 17034364
[TBL] [Abstract][Full Text] [Related]
13. Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2.
Kluve-Beckerman B; Yamada T; Hardwick J; Liepnieks JJ; Benson MD
Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):663-9. PubMed ID: 9065791
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study.
Jylhävä J; Haarala A; Eklund C; Pertovaara M; Kähönen M; Hutri-Kähönen N; Levula M; Lehtimäki T; Huupponen R; Jula A; Juonala M; Viikari J; Raitakari O; Hurme M
J Intern Med; 2009 Sep; 266(3):286-95. PubMed ID: 19702793
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A3 is pro-atherogenic.
Thompson JC; Wilson PG; Shridas P; Ji A; de Beer M; de Beer FC; Webb NR; Tannock LR
Atherosclerosis; 2018 Jan; 268():32-35. PubMed ID: 29175652
[TBL] [Abstract][Full Text] [Related]
16. The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality.
Prüfer N; Kleuser B; van der Giet M
Biol Chem; 2015 Jun; 396(6-7):573-83. PubMed ID: 25252751
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.
Tölle M; Huang T; Schuchardt M; Jankowski V; Prüfer N; Jankowski J; Tietge UJ; Zidek W; van der Giet M
Cardiovasc Res; 2012 Apr; 94(1):154-62. PubMed ID: 22328092
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL₂ and HDL₃.
Gidwani S; Phelan N; McGill J; McGowan A; O'Connor A; Young IS; Gibney J; McEneny J
Hum Reprod; 2014 Jul; 29(7):1518-25. PubMed ID: 24842896
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.
Vaisar T; Tang C; Babenko I; Hutchins P; Wimberger J; Suffredini AF; Heinecke JW
J Lipid Res; 2015 Aug; 56(8):1519-30. PubMed ID: 25995210
[TBL] [Abstract][Full Text] [Related]
20. Why working with porcine circulating serum amyloid A is a pig of a job.
Soler L; Molenaar A; Merola N; Eckersall PD; Gutiérrez A; Cerón JJ; Mulero V; Niewold TA
J Theor Biol; 2013 Jan; 317():119-25. PubMed ID: 23073471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
